Table 3 |
|||||||||||
|
Percentage of antimicrobial resistant strains for the two main Typhimurium STs. |
|||||||||||
|
Antimicrobial resistance |
|||||||||||
|
|
|||||||||||
|
AMPa |
CHL |
SSS |
STR |
TET |
GM |
KM |
NAL |
SXT |
CIPb |
CRO |
|
|
|
|||||||||||
|
ST19 |
61 |
51 |
75 |
80 |
75 |
7 |
10 |
10 |
22 |
0 |
0 |
|
ST213(cmy-2)c |
68 (97) |
90 (94) |
98 (97) |
97 (97) |
97 (100) |
59 (55) |
37 (33) |
72 (61) |
82 (92) |
0 |
53 (100) |
|
|
|||||||||||
|
a AMP:ampicillin, CHL: chloramphenicol, SSS: sulfisoxazole, STR: streptomycin, TET: tetracycline, GM: gentamicin, KM: kanamycin, NAL: nalidixic acid, SXT: timethoprim-sulfametoxazole, CIP: ciprofloxacin, CRO: ceftriaxone. b All the strain were sensitive to CIP according with CLSI [78], including twelve strains with low-level resistance [see Additional file 2]. c The number in parenthesis is the percentage corresponding to ST213 strains positive for cmy-2. |
|||||||||||
|
Wiesner et al. BMC Microbiology 2009 9:131 doi:10.1186/1471-2180-9-131 |
|||||||||||
